Record Details

Probiotics: A potential immunomodulator in COVID-19 infection management

DIR@IMTECH: CSIR-Institute of Microbial Technology

View Archive Info
 
 
Field Value
 
Title Probiotics: A potential immunomodulator in COVID-19 infection management
 
Creator Singh, Kuljit
Rao, Alka
 
Subject QR Microbiology
 
Description COVID-19 caused by SARS-CoV-2 is an ongoing global pandemic. SARS-CoV-2 affects the human respiratory tract's epithelial cells, leading to a proinflammatory cytokine storm and chronic lung inflammation. With numerous patients dying daily, a vaccine and specific antiviral drug regimens are being explored. Probiotics are live microorganisms with proven beneficial effects on human health. While probiotics as nutritional supplements are long practiced in different cuisines across various countries, the emerging scientific evidence supports the antiviral and general immune-strengthening health effects of the probiotics. Here, we present an overview of the experimental studies published in the last 10 years that provide a scientific basis for unexplored probiotics as a preventive approach to respiratory viral infections. Based on collated insights from these experimental data, we identify promising microbial strains that may serve as lead prophylactic and immune-boosting probiotics in COVID-19 management.
 
Publisher Elsevier
 
Date 2021-03
 
Type Article
PeerReviewed
 
Relation https://www.sciencedirect.com/science/article/abs/pii/S0271531720305984
http://crdd.osdd.net/open/2766/
 
Identifier Singh, Kuljit and Rao, Alka (2021) Probiotics: A potential immunomodulator in COVID-19 infection management. NUTRITION RESEARCH, 87. pp. 1-12.